ArchPoint Investors’s Zymergen Inc. Common Stock ZY Stock Holding History

ArchPoint Investors’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-34,000	Closed	-$95K	–	64
2022 Q3	$95K	Hold	34,000	–	–	0.04%	56
2022 Q2	$42K	Buy	34,000 +13,000	+62%	+$21.8K	0.02%	58
2022 Q1	$61K	Buy	21,000 +7,000	+50%	+$29.7K	0.02%	60
2021 Q4	$94K	Buy	+14,000	New	+$136K	0.03%	67

ArchPoint Investors's ZY Position: Q4 2022 in Review

ArchPoint Investors sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 34,000 shares — an estimated $95K sold.

ArchPoint Investors first reported a position in ZY in Q4 2021 and held it in 4 quarters. The position peaked at $95K in Q3 2022. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

ArchPoint Investors reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
ArchPoint Investors sold 34,000 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $95K.
ArchPoint Investors first reported a position in Zymergen Inc. Common Stock in Q4 2021 and held it in 4 quarters.
ArchPoint Investors's Zymergen Inc. Common Stock position peaked at $95K in Q3 2022.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on ArchPoint Investors's 13F filing for Q4 2022, filed 13 Feb 2023.